531 related articles for article (PubMed ID: 17918200)
1. IL-21 regulates experimental colitis by modulating the balance between Treg and Th17 cells.
Fantini MC; Rizzo A; Fina D; Caruso R; Becker C; Neurath MF; Macdonald TT; Pallone F; Monteleone G
Eur J Immunol; 2007 Nov; 37(11):3155-63. PubMed ID: 17918200
[TBL] [Abstract][Full Text] [Related]
2. Regulation of gut inflammation and th17 cell response by interleukin-21.
Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
[TBL] [Abstract][Full Text] [Related]
3. The Th17/Treg imbalance in patients with acute coronary syndrome.
Cheng X; Yu X; Ding YJ; Fu QQ; Xie JJ; Tang TT; Yao R; Chen Y; Liao YH
Clin Immunol; 2008 Apr; 127(1):89-97. PubMed ID: 18294918
[TBL] [Abstract][Full Text] [Related]
4. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
5. IL-21 and IL-21R are not required for development of Th17 cells and autoimmunity in vivo.
Sonderegger I; Kisielow J; Meier R; King C; Kopf M
Eur J Immunol; 2008 Jul; 38(7):1833-8. PubMed ID: 18546146
[TBL] [Abstract][Full Text] [Related]
6. IL-27 controls the development of inducible regulatory T cells and Th17 cells via differential effects on STAT1.
Neufert C; Becker C; Wirtz S; Fantini MC; Weigmann B; Galle PR; Neurath MF
Eur J Immunol; 2007 Jul; 37(7):1809-16. PubMed ID: 17549733
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha blockade exacerbates murine psoriasis-like disease by enhancing Th17 function and decreasing expansion of Treg cells.
Ma HL; Napierata L; Stedman N; Benoit S; Collins M; Nickerson-Nutter C; Young DA
Arthritis Rheum; 2010 Feb; 62(2):430-40. PubMed ID: 20112373
[TBL] [Abstract][Full Text] [Related]
10. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal generation of Th1/Th17 and T(reg) cells by B1 and B2 B cells.
Zhong X; Gao W; Degauque N; Bai C; Lu Y; Kenny J; Oukka M; Strom TB; Rothstein TL
Eur J Immunol; 2007 Sep; 37(9):2400-4. PubMed ID: 17683116
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1 production by CD4+ CD25+ regulatory T cells is not essential for suppression of intestinal inflammation.
Kullberg MC; Hay V; Cheever AW; Mamura M; Sher A; Letterio JJ; Shevach EM; Piccirillo CA
Eur J Immunol; 2005 Oct; 35(10):2886-95. PubMed ID: 16180248
[TBL] [Abstract][Full Text] [Related]
13. Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10.
Maynard CL; Harrington LE; Janowski KM; Oliver JR; Zindl CL; Rudensky AY; Weaver CT
Nat Immunol; 2007 Sep; 8(9):931-41. PubMed ID: 17694059
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of Foxp3(+) gammadelta T cells in mouse and human.
Kang N; Tang L; Li X; Wu D; Li W; Chen X; Cui L; Ba D; He W
Immunol Lett; 2009 Aug; 125(2):105-13. PubMed ID: 19539651
[TBL] [Abstract][Full Text] [Related]
15. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells.
Chen H; Qin J; Wei P; Zhang J; Li Q; Fu L; Li S; Ma C; Cong B
Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):195-200. PubMed ID: 19264469
[TBL] [Abstract][Full Text] [Related]
16. Blocking of IL-6 signaling pathway prevents CD4+ T cell-mediated colitis in a T(h)17-independent manner.
Noguchi D; Wakita D; Tajima M; Ashino S; Iwakura Y; Zhang Y; Chamoto K; Kitamura H; Nishimura T
Int Immunol; 2007 Dec; 19(12):1431-40. PubMed ID: 17981790
[TBL] [Abstract][Full Text] [Related]
17. 8-methoxypsoralen plus ultraviolet A therapy acts via inhibition of the IL-23/Th17 axis and induction of Foxp3+ regulatory T cells involving CTLA4 signaling in a psoriasis-like skin disorder.
Singh TP; Schön MP; Wallbrecht K; Michaelis K; Rinner B; Mayer G; Schmidbauer U; Strohmaier H; Wang XJ; Wolf P
J Immunol; 2010 Jun; 184(12):7257-67. PubMed ID: 20488788
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta-exposed plasmacytoid dendritic cells participate in Th17 commitment.
Bonnefoy F; Couturier M; Clauzon A; Rémy-Martin JP; Gaugler B; Tiberghien P; Chen W; Saas P; Perruche S
J Immunol; 2011 Jun; 186(11):6157-64. PubMed ID: 21518970
[TBL] [Abstract][Full Text] [Related]
19. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis.
Fletcher JM; Lonergan R; Costelloe L; Kinsella K; Moran B; O'Farrelly C; Tubridy N; Mills KH
J Immunol; 2009 Dec; 183(11):7602-10. PubMed ID: 19917691
[TBL] [Abstract][Full Text] [Related]
20. Smad2 and Smad3 are redundantly essential for the TGF-beta-mediated regulation of regulatory T plasticity and Th1 development.
Takimoto T; Wakabayashi Y; Sekiya T; Inoue N; Morita R; Ichiyama K; Takahashi R; Asakawa M; Muto G; Mori T; Hasegawa E; Saika S; Hara T; Nomura M; Yoshimura A
J Immunol; 2010 Jul; 185(2):842-55. PubMed ID: 20548029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
